If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Session Summary
Explore the transformative power of trauma-informed care in enhancing psychiatric and other health outcomes, particularly for members of marginalized communities. This session will highlight the pervasive and cyclical impact of trauma on the social determinants of health and demonstrate how adopting a trauma-informed approach can significantly improve patient engagement and treatment outcomes. Learn practical strategies for integrating trauma-informed principles into treatment plans, communication, and documentation, fostering a more compassionate and effective care environment.
Faculty Information
Marie A. Chisholm-Burns, PhD, PharmD, MBA, MPH, FCCP, FASHP, FAST, FACHE
Marie A. Chisholm-Burns, PhD, PharmD, MBA, MPH, FCCP, FASHP, FAST, FACHE
Executive Vice President, Provost, and J.S. Reinschmidt Professor
Oregon Health & Science University
Portland, OR
Marie A. Chisholm-Burns, PharmD, PhD, MPH, MBA, FCCP, FASHP, FAST, FACHE, is the Executive Vice President and Provost of Oregon Health & Science University (OHSU). She is also the J.S. Reinschmidt Endowed Professor in the OHSU School of Medicine. She previously served as Dean and Distinguished Professor of the University of Tennessee Health Science Center College of Pharmacy, as Professor and Head of the Department of Pharmacy Practice and Science at the University of Arizona College of Pharmacy, and as faculty at the University of Georgia College of Pharmacy. Guided by a driving vision to make a difference, Dr. Chisholm-Burns is a strong proponent of initiatives, services, and opportunities to advance access and success among patients, students, faculty, staff, and other stakeholders.
Dr. Chisholm-Burns has a BS in Pharmacy degree, Doctor of Pharmacy degree, Master of Public Health degree, Master of Business Administration degree, and Doctor of Philosophy degree with an emphasis in Health Sciences. She completed her residency at Piedmont Hospital and Mercer University Southern School of Pharmacy in Atlanta, Georgia. Dr. Chisholm-Burns is Founder and Director of the Medication Access Program which increases medication access to solid-organ transplant recipients. She is Treasurer and Commissioner on the Northwest Commission on Colleges and Universities Board of Commissioners, and a member of the American Society of Health-System Pharmacists Board of Directors, the State of Oregon Racial Justice Council – Education Committee, the Oregon Museum of Science and Industry Board of Trustees, and the National Academies of Practice. She served as a Commissioner on the State of Tennessee Education Recovery and Innovation Commission and was a member of the Accreditation Council for Pharmacy Education (ACPE) Board of Directors and the American Society of Transplantation Board of Directors. She has also served in numerous elected leadership positions in several different professional organizations and worked in multiple pharmacy settings. She participated as an accreditation site evaluator for ACPE, Southern Association of Colleges and Schools Commission on Colleges, and Western Association for Schools and Colleges Senior College and University Commission.
A dedicated scholar, Dr. Chisholm-Burns has more than 390 publications and over $19 million in external funding as principal investigator and co-investigator from organizations such as the National Institutes of Health and several foundations. She has published several textbooks that have been adopted in many schools. In 2008 and 2011, textbooks co-edited by Dr. Chisholm-Burns, Pharmacotherapy Principles and Practice and Pharmacy Management, Leadership, Marketing, and Finance, respectively, received the Medical Book Award from the American Medical Writers Association. She has received numerous awards and honors from national professional organizations including the Award for Sustained Contributions to the Literature, Research Achievement Award, Nicholas Andrew Cummings Award, Award of Excellence, Joint Leadership Award, Clinician of Distinction Award, Paul R. Dawson Biotechnology Award, Robert K. Chalmers Distinguished Pharmacy Educator Award, Clinical Pharmacy Education Award, Daniel B. Smith Practice Excellence Award, Rufus A. Lyman Award for most outstanding publication in the American Journal of Pharmaceutical Education (1996 and 2007), Pharmacy Practice Research Award (2011 and 2014), Chauncey I. Cooper Pharmacist Leadership Award, Russell R. Miller Award, and Distinguished Teaching Scholar Award.
Learning Objectives
Define social determinants of health (SDOH), trauma, and trauma-informed care.
Identify the impact that trauma has on SDOH (and vice versa), especially in members of marginalized communities.
Describe how addressing SDOH can improve patient engagement and outcomes.
Explain how trauma-informed care principles can be applied to treatment, communication, and documentation strategies in practice.
Continuing Education Credit and Disclosures
Activity Date: 04/29/2025 ACPE Contact Hours: 1.25 ACPE Number: 0284-0000-25-014-L04-P (Knowledge) Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.
AAPP websites use cookies to personalize and enhance your experience.
By continuing to use the site, you agree to this collection.
Learn more.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.